|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bria E, De Manzoni G, Beghelli S,
Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero
M, Sperduti I, et al: A clinical-biological risk stratification
model for resected gastric cancer: Prognostic impact of Her2, Fhit,
and APC expression status. Ann Oncol. 24:693–701. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng PL, Zhou XY, Yi GD, Chen PF, Wang F
and Dong WG: Identification of a novel gene pairs signature in the
prognosis of gastric cancer. Cancer Med. 7:344–350. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akhondi-Meybodi M, Ghane M,
Akhondi-Meybodi S and Dashti G: Five-year survival rate for gastric
cancer in Yazd Province, Central Iran, from 2001 to 2008. Middle
East J Dig Dis. 9:39–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bass AJ, Thorsson V, Shmulevich I,
Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C,
Shen H, et al: Comprehensive molecular characterization of gastric
adenocarcinoma. Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lei T, Zhu Y, Jiang C, Wang Y, Fu J, Fan Z
and Qin H: MicroRNA-320 was downregulated in non-small cell lung
cancer and inhibited cell proliferation, migration and invasion by
targeting fatty acid synthase. Mol Med Rep. 14:1255–1262. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hagan JP and Croce CM: MicroRNAs in
carcinogenesis. Cytogenet Genome Res. 118:252–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia E, Kanematsu S, Suenaga Y, Elzawahry
A, Kondo H, Otsuka N, Moriya Y, Iizasa T, Kato M, Yoshino I and
Yokoi S: MicroRNA induction by copy number gain is associated with
poor outcome in squamous cell carcinoma of the lung. Sci Rep.
8:153632018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kundu A, Quirit JG, Khouri MG and
Firestone GL: Inhibition of oncogenic BRAF activity by
indole-3-carbinol disrupts microphthalmia-associated transcription
factor expression and arrests melanoma cell proliferation. Mol
Carcinog. 56:49–61. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma X, Feng J, Lu M, Tang W, Han J, Luo X,
Zhao Q and Yang L: microRNA-501-5p promotes cell proliferation and
migration in gastric cancer by downregulating LPAR1. J Cell
Biochem. 121:1911–1922. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu H, Zhang J, Wen Q, Dai Y, Zhang W, Li F
and Li J: MicroRNA-6852 suppresses cell proliferation and invasion
via targeting forkhead box J1 in gastric cancer. Exp Ther Med.
16:3249–3255. 2018.PubMed/NCBI
|
|
14
|
Liu J, Wei Y, Li S, Li Y, Liu H, Liu J and
Zhu X: MicroRNA-744 promotes cell apoptosis via targeting B cell
lymphoma-2 in gastric cancer cell line SGC-7901. Exp Ther Med.
16:3611–3616. 2018.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai H, Lin H, Cao W, Sun J, Huang Y and
Fang Y: Downregulation of miR-519a predicts poor prognosis and
contributes to tumor progression in gastric cancer. Oncol Res
Treat. 43:19–26. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen S, Li F, Chai H, Tao X, Wang H and Ji
A: miR-502 inhibits cell proliferation and tumor growth in
hepatocellular carcinoma through suppressing phosphoinositide
3-kinase catalytic subunit gamma. Biochem Biophys Res Commun.
464:500–505. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun LL, Wang J, Zhao ZJ, Liu N, Wang AL,
Ren HY, Yang F, Diao KX, Fu WN, Wan EH and Mi XY: Suppressive role
of miR-502-5p in breast cancer via downregulation of TRAF2. Oncol
Rep. 31:2085–2092. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhai H, Song B, Xu X, Zhu W and Ju J:
Inhibition of autophagy and tumor growth in colon cancer by
miR-502. Oncogene. 32:1570–1579. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beishline K and Azizkhan-Clifford J: Sp1
and the ‘hallmarks of cancer’. FEBS J. 282:224–258. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chakraborty G, Rangaswami H, Jain S and
Kundu GC: Hypoxia regulates cross-talk between Syk and Lck leading
to breast cancer progression and angiogenesis. J Biol Chem.
281:11322–11331. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Jiang Y, Xie Y, Leng X, He M and
Song F: Long noncoding RNA TRPM2-AS induced by SP1 inhibits cell
apoptosis via MAPK and STAT3 in gastric cancer. J Gastroenterol
Hepatol. May 18–2020.(Epub ahead of print). View Article : Google Scholar
|
|
23
|
Guan H, Cai J, Zhang N, Wu J, Yuan J, Li J
and Li M: Sp1 is upregulated in human glioma, promotes
MMP-2-mediated cell invasion and predicts poor clinical outcome.
Int J Cancer. 130:593–601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kou XX, Hao T, Meng Z, Zhou YH and Gan YH:
Acetylated Sp1 inhibits PTEN expression through binding to PTEN
core promoter and recruitment of HDAC1 and promotes cancer cell
migration and invasion. Carcinogenesis. 34:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee HS, Park CK, Oh E, Erkin ÖC, Jung HS,
Cho MH, Kwon MJ, Chae SW, Kim SH, Wang LH, et al: Low SP1
expression differentially affects intestinal-type compared with
diffuse-type gastric adenocarcinoma. PLoS One. 8:e555222013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu TI, Wang MC, Chen SY, Yeh YM, Su WC,
Chang WC and Hung JJ: Sp1 expression regulates lung tumor
progression. Oncogene. 31:3973–3988. 2012. View Article : Google Scholar : PubMed/NCBI
|
